午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Interrogation drug prices artificially high The national "two votes"
 
Author:中國銘鉉 企劃部  Release Time:2017-1-12 9:20:27  Number Browse:1194
 

Medical network - January 10th national "two votes" file formal fall to the ground. On January 9, the national health and family planning commission held a press conference, emphasis on "on drug procurement in the public medical institutions in implementing the implementation of the" two votes "opinion (trial) notice (hereinafter referred to as the" notice ").

"Two votes" refers to drug from the production enterprise to open an invoice of enterprises and circulation enterprises to open an invoice of medical institutions. "Notice" clear, the public medical institutions and drug procurement to gradually implement the "two votes", encourage other medical institutions to implement the "two votes", comprehensive reform pilot provinces and public hospital reform pilot city public medical institutions should take the lead in implementation of "two votes", encouraging other area to implement the "two votes", in the national push for 2018.

"This is an important reform measures medicine field, its purpose is to reduce the drug circulation, make the middle price transparency, further reducing drug prices artificially high, ease the burden." Reform of the state council for full-time, deputy director of the national health and family planning commission TiGaiSi chief priests Liang Wannian said at the news conference, the problem of drug prices artificially high has a long history, is the current reform must solve a problem, is also a strong calls for the people.

"In the past drug from manufacturer to the medical institutions should pass more ticket link, some four votes, five, or even more, layers of overweight, higher drug prices. Drug price, sales to the medical institutions, on the one hand, people want to pay more, on the other hand, medical insurance fund to pay more, so this problem must be solved." , he said, "two votes", from the perspective of the circulation field, many link down to "two votes", greatly reduce the middle of the water, for the common people and save the medical insurance fund cost, ensure the safety of medical insurance fund.

It is important to note that in order to ensure the "two votes" smooth, guarantee the timely and effective drug supply, "notice" has made the special provisions on the following four: it is both accords with the trend of the development of modern pharmaceutical enterprise, trade and industry of pharmaceutical production enterprise or the integration of the group enterprises set up by the only sales of the enterprises wholly owned or holding (group) pharmaceutical business company (only a commercial company) across the country, foreign drug domestic general agent (the only one domestic general agent) can be regarded as production enterprise. Of drug circulation group enterprise to a wholly owned subsidiary (holding) or a wholly owned subsidiary (holding) transfers between drug is not seen as a vote, but most allow open an invoice. 2 it is to ensure the effective supply of basic drugs, medicine circulation enterprises as a special remote, inaccessible township (town) and village-level medical institutions distribution drugs, allowed on the basis of the "two votes" to open a pharmaceutical sales invoice. Three is in response to natural disasters, major outbreaks, major events and the patient (rob) save the special circumstances, such as emergency purchasing drugs or national pharmaceutical reserve drugs, can carry out special processing. Four is to narcotic drugs and circulation management, psychotropic drugs of category I still according to the regulations of the state.

"Two votes" to implement the important influence on the medicine circulation industry, is conducive to standardize the order of medicine circulation industry, interpromotion reorganization of circulation industry small and disorderly competition environment, to enhance industry concentration has a positive role. The economic information daily, reporter interview of the personage inside course of study thinks, from the file content, large circulation enterprises have positive, agent wholesale enterprises and a ticket for the main business prospects are grim, prefecture-level distribution tap opportunities for development, reserve agency model will have the biggest challenge.

Public data shows that at present our country a total of more than 13000 drug wholesale business licenses of circulation enterprises, annual sales of more than 50 million yuan less than 5% of the enterprise, concentration of wide disparity compared with developed countries.

The industry insiders said, according to the policy design, since the implementation of the "two votes" part of the enterprise in the past by a ticket business company to complete basic by breaking the cycle of capital cost, make a ticket for a long time of the company's survival space is compressed, ticket function collapse. The documents specified in the "two votes" countries, medicine circulation group enterprise with wholly owned subsidiaries (holding) or a wholly owned subsidiary (holding) transfers between drug is not seen as a vote, will definitely good group medicine circulation enterprises.

The people also think that with the policy implementation, a large number of agents type medicine commercial companies, small and medium-sized pharmaceutical commercial companies certainly will need to transform or seek takeover, to further speed up to large pharmaceutical circulation enterprises group mergers and reorganization release opportunity, further improve the concentration of drug distribution. In addition, the "two votes", to increase, circulation regulation and a series of policy mix, national general agent may be gradually disappear.

 
Previous article:Drug zero bonus this year national coverage! How will you spend three shut?
Next article:2013~2015In retail pharmacies proprietary Chinese medicine main competitive product analysis
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號